StockData
Virax Biolabs Group Ltd logo

Virax Biolabs Group Ltd (VRAX) stock

VRAXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 6, 2026Score 9/30
$0.45−0.16 (-26.87%)

Close on Nov 16, 2026Market cap $259.49KP/E –Yield –

Virax Biolabs total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Virax Biolabs

Virax Biolabs has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Virax Biolabs figures

See a number that looks wrong?